These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 8053422)
1. Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease. Peura DA; Graham DY Am J Gastroenterol; 1994 Aug; 89(8):1137-9. PubMed ID: 8053422 [No Abstract] [Full Text] [Related]
2. [Treatment of peptic ulcer and gastritis associated with Helicobacter pylori]. López-Brea M; Alarcón T Enferm Infecc Microbiol Clin; 1995; 13(7):422-8. PubMed ID: 8519820 [No Abstract] [Full Text] [Related]
3. [Resolution of an autoimmune thrombocytopenic purpura after eradicating treatment of Helicobacter pylori]. García Pérez A; Valverde de La Osa J; Giménez Samper M; Alonso García I Sangre (Barc); 1999 Oct; 44(5):387-8. PubMed ID: 10618919 [No Abstract] [Full Text] [Related]
10. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori. Laine L; Estrada R; Trujillo M; Emami S Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755 [TBL] [Abstract][Full Text] [Related]
11. Eczema responsive to treatment for Helicobacter pylori. Wilson WH Ann Allergy Asthma Immunol; 1995 Sep; 75(3):290. PubMed ID: 7552934 [No Abstract] [Full Text] [Related]
12. Eradication of Helicobacter pylori reduces gastric and duodenal ulcer recurrence. Laine L Gastroenterology; 1992 Nov; 103(5):1695-6. PubMed ID: 1426890 [No Abstract] [Full Text] [Related]
13. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial. Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657 [TBL] [Abstract][Full Text] [Related]
14. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial. Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068 [TBL] [Abstract][Full Text] [Related]
15. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication. Avidan B; Melzer E; Keller N; Bar-Meir S Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370 [TBL] [Abstract][Full Text] [Related]
16. Peptic ulcer treatment today--is there a role for maintenance therapy? Breslin NP; O'Morain C Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):116-21. PubMed ID: 9646190 [No Abstract] [Full Text] [Related]
17. Identification and eradication of Helicobacter pylori in an isolated patient population. Myers D Mil Med; 1997 Jul; 162(7):507-9. PubMed ID: 9232984 [TBL] [Abstract][Full Text] [Related]
18. [Helicobacter pylori: can it be a contributing factor in peptic ulcer in childhood?]. Tovar-Calderón S; Casaubón-Garcín P; Ramírez-Mayans J; Cervantes R Bol Med Hosp Infant Mex; 1991 Oct; 48(10):743-8. PubMed ID: 1764199 [TBL] [Abstract][Full Text] [Related]
19. Significance of a tetracycline and Pepto-Bismol interaction in the management of Helicobacter pylori-induced peptic ulcer disease. Tkach CL; Ariano RE Ann Pharmacother; 1998 Mar; 32(3):387. PubMed ID: 9533072 [No Abstract] [Full Text] [Related]
20. Helicobacter pylori in peptic ulcer disease. Del Med J; 1994 Oct; 66(10):557-8. PubMed ID: 7958122 [No Abstract] [Full Text] [Related] [Next] [New Search]